Related Experiment Video
Updated: Jul 6, 2026

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease
Published on: October 4, 2021
Dopa-responsive dystonia presenting as delayed and awkward gait.
Benjamin N R Cheyette1, Sarah N R Cheyette, Kristina Cusmano-Ozog
1Department of Psychiatry, Center for Neurobiology and Psychiatry, University of California at San Francisco, San Francisco, California 94158-2324, USA. bc@lppi.ucsf.edu
Dopa-responsive dystonia, caused by GCH1 gene mutations, presents variably. This study details a toddler with the condition, highlighting diverse GCH1 mutation impacts within a family.
Area of Science:
- Genetics
- Neurology
- Biochemistry
Background:
- Dopa-responsive dystonia (DRD) is a genetic disorder affecting dopamine synthesis.
- Autosomal-dominant DRD is often linked to mutations in the guanosine triphosphate (GTP)-cyclohydrolase 1 (GCH1) gene.
- Clinical presentation of DRD, including dystonia, onset, and severity, can be highly variable.
Observation:
- A male toddler presented with symptoms of dopa-responsive dystonia.
- Genetic analysis revealed an autosomal-dominant mutation in the GCH1 gene.
- Three additional family members were identified as carriers of the same GCH1 mutation.
Findings:
- The identified GCH1 mutation in the toddler led to dopa-responsive dystonia.
- Family members carrying the same mutation exhibited a wide spectrum of clinical severity and functional consequences.
- This case underscores the variable penetrance and expressivity of GCH1 mutations in DRD.
Implications:
- Understanding GCH1 mutation variability is crucial for accurate DRD diagnosis and management.
- Further research into factors influencing GCH1 allele penetrance can improve patient outcomes.
- This study contributes to the knowledge base of hereditary neurodegenerative disorders and genetic counseling.
More Related Videos
05:51Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
Published on: October 14, 2021
10:41Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia
Published on: September 12, 2020
Related Concept Videos
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Alterations in Muscle Tone ll
Alterations in Muscle Tone lll
Parkinson's Disease: Overview
Parkinson Disease l: Introduction
Huntington Disease l: Introduction